These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Antinociceptive action of 4-methyl-5-trifluoromethyl-5-hydroxy-4, 5-dihydro-1H-pyrazole methyl ester in models of inflammatory pain in mice. Milano J; Rossato MF; Oliveira SM; Drewes C; Machado P; Beck P; Zanatta N; Martins MA; Mello CF; Rubin MA; Ferreira J; Bonacorso HG Life Sci; 2008 Nov; 83(21-22):739-46. PubMed ID: 18848839 [TBL] [Abstract][Full Text] [Related]
3. Opioid antinociception in a rat model of visceral pain: systemic versus local drug administration. Craft RM; Henley SR; Haaseth RC; Hruby VJ; Porreca F J Pharmacol Exp Ther; 1995 Dec; 275(3):1535-42. PubMed ID: 8531126 [TBL] [Abstract][Full Text] [Related]
4. Kappa opioid antagonist effects of systemically administered nor-binaltorphimine in a thermal antinociception assay in rhesus monkeys. Butelman ER; Negus SS; Ai Y; de Costa BR; Woods JH J Pharmacol Exp Ther; 1993 Dec; 267(3):1269-76. PubMed ID: 8263790 [TBL] [Abstract][Full Text] [Related]
7. Opioid interactions in rhesus monkeys: effects of delta + mu and delta + kappa agonists on schedule-controlled responding and thermal nociception. Stevenson GW; Folk JE; Linsenmayer DC; Rice KC; Negus SS J Pharmacol Exp Ther; 2003 Dec; 307(3):1054-64. PubMed ID: 14557380 [TBL] [Abstract][Full Text] [Related]
8. Mother root of Aconitum carmichaelii Debeaux exerts antinociceptive effect in Complet Freund's Adjuvant-induced mice: roles of dynorpin/kappa-opioid system and transient receptor potential vanilloid type-1 ion channel. Wang C; Sun D; Liu C; Zhu C; Jing X; Chen S; Liu C; Zhi K; Xu T; Wang H; Liu J; Xu Y; Liu Z; Lin N J Transl Med; 2015 Aug; 13():284. PubMed ID: 26320055 [TBL] [Abstract][Full Text] [Related]
9. LY2456302 is a novel, potent, orally-bioavailable small molecule kappa-selective antagonist with activity in animal models predictive of efficacy in mood and addictive disorders. Rorick-Kehn LM; Witkin JM; Statnick MA; Eberle EL; McKinzie JH; Kahl SD; Forster BM; Wong CJ; Li X; Crile RS; Shaw DB; Sahr AE; Adams BL; Quimby SJ; Diaz N; Jimenez A; Pedregal C; Mitch CH; Knopp KL; Anderson WH; Cramer JW; McKinzie DL Neuropharmacology; 2014 Feb; 77():131-44. PubMed ID: 24071566 [TBL] [Abstract][Full Text] [Related]
10. Opioid antagonist profile of SC nor-binaltorphimine in the formalin paw assay. Wettstein JG; Grouhel A Pharmacol Biochem Behav; 1996 Feb; 53(2):411-6. PubMed ID: 8808151 [TBL] [Abstract][Full Text] [Related]
11. A pharmacological profile of the novel, peripherally-selective kappa-opioid receptor agonist, EMD 61753. Barber A; Bartoszyk GD; Bender HM; Gottschlich R; Greiner HE; Harting J; Mauler F; Minck KO; Murray RD; Simon M Br J Pharmacol; 1994 Dec; 113(4):1317-27. PubMed ID: 7889287 [TBL] [Abstract][Full Text] [Related]
12. Differential antagonism of U69,593- and bremazocine-induced antinociception by (-)-UPHIT: evidence of kappa opioid receptor multiplicity in mice. Horan P; de Costa BR; Rice KC; Porreca F J Pharmacol Exp Ther; 1991 Jun; 257(3):1154-61. PubMed ID: 1646325 [TBL] [Abstract][Full Text] [Related]
13. 3-Methyl-5-hydroxy-5-trichloromethyl-1H-1-pyrazolcarboxyamide induces antinociception. de Souza FR; Fighera MR; Lima TT; de Bastiani J; Barcellos IB; Almeida CE; de Oliveira MR; Bonacorso HG; Flores AE; de Mello CF Pharmacol Biochem Behav; 2001 Mar; 68(3):525-30. PubMed ID: 11325408 [TBL] [Abstract][Full Text] [Related]
14. Intracisternal nor-binaltorphimine distinguishes central and peripheral kappa-opioid antinociception in rhesus monkeys. Ko MC; Johnson MD; Butelman ER; Willmont KJ; Mosberg HI; Woods JH J Pharmacol Exp Ther; 1999 Dec; 291(3):1113-20. PubMed ID: 10565831 [TBL] [Abstract][Full Text] [Related]
15. Antinociceptive properties of FR140423 mediated through spinal delta-, but not mu- and kappa-, opioid receptors. Ochi T; Fujii T; Motoyama Y; Goto T Eur J Pharmacol; 1999 Sep; 380(2-3):73-9. PubMed ID: 10513565 [TBL] [Abstract][Full Text] [Related]
17. Alpha 2-adrenoceptors and 5-HT receptors mediate the antinociceptive effect of new pyrazolines, but not of dipyrone. Godoy MC; Fighera MR; Souza FR; Flores AE; Rubin MA; Oliveira MR; Zanatta N; Martins MA; Bonacorso HG; Mello CF Eur J Pharmacol; 2004 Aug; 496(1-3):93-7. PubMed ID: 15288580 [TBL] [Abstract][Full Text] [Related]
18. Peripheral antinociceptive effects of the cyclic endomorphin-1 analog c[YpwFG] in a mouse visceral pain model. Bedini A; Baiula M; Gentilucci L; Tolomelli A; De Marco R; Spampinato S Peptides; 2010 Nov; 31(11):2135-40. PubMed ID: 20713109 [TBL] [Abstract][Full Text] [Related]
19. In vitro binding affinities of a series of flavonoids for μ-opioid receptors. Antinociceptive effect of the synthetic flavonoid 3,3-dibromoflavanone in mice. Higgs J; Wasowski C; Loscalzo LM; Marder M Neuropharmacology; 2013 Sep; 72():9-19. PubMed ID: 23624290 [TBL] [Abstract][Full Text] [Related]
20. Tramadol antinociception is potentiated by clonidine through α₂-adrenergic and I₂-imidazoline but not by endothelin ET(A) receptors in mice. Andurkar SV; Gendler L; Gulati A Eur J Pharmacol; 2012 May; 683(1-3):109-15. PubMed ID: 22449379 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]